Pathological forms of brain electrical activity and localization of its sources in patients with trigeminal neuralgia

Protein binding of oxcarbazepine and its

Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia

✍ P. N. Patsalos; A. A. Elyas; J. M. Zakrzewska 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 313 KB

Oxcarbazepine, a new drug with antineuralgic properties has been evaluated in a long-term follow-up of 6 patients (2 males, 4 females; aged 42-77 years; mean 61 years), previously reported on with trigeminal neuralgia. Daily oral oxcarbazepine dose correlated significantly with both total oxcarbazep